
Tailoring neoadjuvant therapy in rectal cancer based on risk classification improves outcomes.


coremsg

Neoadjuvant chemoradiotherapy can be omitted in low-risk rectal cancer patients without compromising outcomes, but intensified in high-risk patients, new findings suggest.

Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer?

risk-adapted-neoadjuvant-chemoradiotherapy-in-rectal-cancer-study-findings


Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer Study Findings
